Liquidia Corporation (LQDA) key performance indicators and operating metrics (5 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| Adjusted Earnings Before Interest, Taxes, Depreciation, and Amortization | 71.22M | FY2026-Q1 |
| Net Product Sales (YUTREPIA) | 129.88M | FY2026-Q1 |
| Service Revenue, Net (Santos Promotion Agreement) | 2.98M | FY2026-Q1 |
| Patients Started on Therapy (YUTREPIA) | 3.75K | FY2026-Q1 |
| Unique Patient Prescriptions (YUTREPIA) | 4.5K | FY2026-Q1 |
Back to LQDA overview · LQDA earnings · LQDA holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.